Issue Lab
Every day, more than 1,000,000 biopharmaceutical industry employees across the United States work to research, develop and manufacture lifesaving medicines and treatments. It is important to have public policies that encourage and support continued medical innovation, while also improving patient access to affordable medicines.

We aim to protect access, innovation and jobs.
Unfortunately, some policymakers have proposed policies that would chill investment in science, threaten access to medicines and put jobs at risk.
Employee Champions
Meet the recipients of the 2024 Employee Champions Awards. This award recognizes individuals who strive to advance science and support innovation so that patients around the world can get the medicines and treatments they need.

Ian Hunt
Global Head of Scientific Engagement
Novartis

Dr. Megan O’Meara
Head of Oncology Early-Stage Development
Pfizer

Dr. Jeffrey Stark
Vice President and Head, U.S. Medical Immunology
UCB

Mike Edmondson
Vice President
Amgen

Liv Gagne
Lead, Patient Partnerships
Astellas

Shaun Venable
Head of Corporate Communications at Biogen’s Research Triangle Park (RTP) Campus
Biogen

Neil Bence
Vice President, Head of Oncology Discovery
Bristol Myers Squibb

Ram Gupta
Director, National Accounts
Genmab

Dr. Jim Hartke
Vice President, Nonclinical Safety and Pathobiology
Gilead Sciences

John Capriotti
Sr. Director, Market Access, Contract Operations
GSK

Pearl Pugh
President of Neuroscience
Johnson & Johnson

Petr Vachal, Ph.D.
Associate Vice President, Discovery Chemistry
Merck

Ian Hunt
Global Head of Scientific Engagement
Novartis

Dr. Megan O’Meara
Head of Oncology Early-Stage Development
Pfizer

Dr. Jeffrey Stark
Vice President and Head, U.S. Medical Immunology
UCB

Mike Edmondson
Vice President
Amgen

Liv Gagne
Lead, Patient Partnerships
Astellas

Shaun Venable
Head of Corporate Communications at Biogen’s Research Triangle Park (RTP) Campus
Biogen

Neil Bence
Vice President, Head of Oncology Discovery
Bristol Myers Squibb

Ram Gupta
Director, National Accounts
Genmab

Dr. Jim Hartke
Vice President, Nonclinical Safety and Pathobiology
Gilead Sciences

John Capriotti
Sr. Director, Market Access, Contract Operations
GSK

Pearl Pugh
President of Neuroscience
Johnson & Johnson

Petr Vachal, Ph.D.
Associate Vice President, Discovery Chemistry
Merck

Ian Hunt
Global Head of Scientific Engagement
Novartis

Dr. Megan O’Meara
Head of Oncology Early-Stage Development
Pfizer

Dr. Jeffrey Stark
Vice President and Head, U.S. Medical Immunology
UCB